Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease
- PMID: 18612318
- DOI: 10.1038/jcbfm.2008.67
Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease
Erratum in
- J Cereb Blood Flow Metab. 2009 Apr;29(4):871
Abstract
Moyamoya disease (MMD) is an unusual form of chronic cerebrovascular occlusive disease that involves the formation of characteristically abnormal vessels. Recent studies have reported that colony-forming unit (CFU) and outgrowth cells represent a subpopulation of endothelial progenitor cells (EPCs). Here, we attempted to determine the significance of CFU number and outgrowth cell yield in MMD. Endothelial progenitor cells were isolated from the blood of 24 adult MMD patients and from 48 age- and risk factor-matched control subjects. After 7 days of culture, CFUs were determined, and yields of outgrowth cells were measured during 2 months of culture. The EPC function was also evaluated using matrigel plate assays. It was found that CFU numbers were significantly lower in MMD patients than in controls. Moreover, during long-term culture, outgrowth cells were isolated from only 10% of control subjects but from 33% of MMD patients, and CFU numbers and tube formation were found to be lower in advanced MMD cases than in those with early stage disease, whereas outgrowth cells were more frequently detected in those with early MMD and moyamoya vessels than in those with advanced disease. These characteristics of circulating EPCs reflect mixed conditions of vascular occlusion and abnormal vasculogenesis during the pathogenesis of MMD.
Similar articles
-
Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke.Stroke. 2008 May;39(5):1441-7. doi: 10.1161/STROKEAHA.107.499236. Epub 2008 Mar 20. Stroke. 2008. PMID: 18356550
-
Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.Stroke. 2009 Feb;40(2):432-8. doi: 10.1161/STROKEAHA.108.529420. Epub 2008 Dec 18. Stroke. 2009. PMID: 19095988
-
Effectiveness of Superficial Temporal Artery-to-Middle Cerebral Artery Anastomosis in Treating Moyamoya Disease by Reducing Endothelial Progenitor Cells.World Neurosurg. 2016 Sep;93:365-70. doi: 10.1016/j.wneu.2016.06.063. Epub 2016 Jun 24. World Neurosurg. 2016. PMID: 27350298 Clinical Trial.
-
Pathological Circulating Factors in Moyamoya Disease.Int J Mol Sci. 2021 Feb 8;22(4):1696. doi: 10.3390/ijms22041696. Int J Mol Sci. 2021. PMID: 33567654 Free PMC article. Review.
-
An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues.Neurol Res. 2014 May;36(5):407-16. doi: 10.1179/1743132814Y.0000000351. Epub 2014 Mar 18. Neurol Res. 2014. PMID: 24641716 Review.
Cited by
-
Identification of diagnostic markers for moyamoya disease by combining bulk RNA-sequencing analysis and machine learning.Sci Rep. 2024 Mar 11;14(1):5931. doi: 10.1038/s41598-024-56367-w. Sci Rep. 2024. PMID: 38467737 Free PMC article.
-
Liquid chromatography coupled to mass spectrometry metabolomic analysis of cerebrospinal fluid revealed the metabolic characteristics of moyamoya disease.Front Neurol. 2024 Feb 15;15:1298385. doi: 10.3389/fneur.2024.1298385. eCollection 2024. Front Neurol. 2024. PMID: 38426176 Free PMC article.
-
Mass cytometry revealed the circulating immune cell landscape across different Suzuki stages of Moyamoya disease.Immunol Res. 2024 Feb 20. doi: 10.1007/s12026-024-09464-x. Online ahead of print. Immunol Res. 2024. PMID: 38376705
-
Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases.Front Neurol. 2023 May 16;14:661611. doi: 10.3389/fneur.2023.661611. eCollection 2023. Front Neurol. 2023. PMID: 37273690 Free PMC article. Review.
-
Combination of indirect revascularization and endothelial progenitor cell transplantation improved cerebral perfusion and ameliorated tauopathy in a rat model of bilateral ICA ligation.Stem Cell Res Ther. 2022 Nov 12;13(1):516. doi: 10.1186/s13287-022-03196-1. Stem Cell Res Ther. 2022. PMID: 36371197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
